Merck Hit With Antitrust Suit Over Settlement for 2 Best-Selling Drugs

Merck has been hit with an antitrust action in New Jersey district court, which claimed that the company entered into an anticompetitive settlement agreement and an unlawful business arrangement in violation of antitrust and consumer protection laws in relation to two  cholesterol-reducing drugs.

This suit was surfaced by Radar, ALM’s source for immediate alerting on just filed cases in state and federal courts. Radar now offers state court coverage nationwide. Sign up today and be first to know about new suits in your region, practice area or client sector.

Leave a Comment

Your email address will not be published. Required fields are marked *